SCHEMBL798373

SCHEMBL798373

CCCC(Cc1cccc(OC)c1)[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.51
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
CRHBP P24387 1/20 0.45
KMT2A Q03164 1/20 0.45
CRHR2 Q13324 1/20 0.45
CMA1 P23946 1/20 0.42
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
IDO1 P14902 2/20 0.42
AGXT P21549 2/20 0.42
CHRM2 P08172 3/20 0.41
CHRM1 P11229 2/20 0.41
CHRM3 P20309 2/20 0.41
FBP1 P09467 1/20 0.40
EPHX2 P34913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4555592 0.84 ALOX5 (0.46) MEN1ALDH1A1KMT2A
SCHEMBL8765867 0.84 CYP1A2 (0.47) TAAR1MEN1ALDH1A1POLBMAPT
SCHEMBL9544466 0.84 CYP1A2 (0.47) TAAR1MEN1ALDH1A1POLBMAPT
SCHEMBL8765558 0.80 TAAR1 (0.43) TAAR1MEN1ALDH1A1POLBMAPT
SCHEMBL9356423 0.79 CPA1 (0.44) TAAR1POLB
SCHEMBL14402404 0.75 TAAR1 (0.58) TAAR1CMA1TAS1R3TAS1R1IDO1
SCHEMBL14402407 0.75 TAAR1 (0.58) TAAR1TAS1R3TAS1R1IDO1AGXT
SCHEMBL13849891 0.75 TAAR1 (0.58) TAAR1TAS1R3TAS1R1IDO1AGXT
SCHEMBL13349249 0.75 TAAR1 (0.68) TAAR1IDO1AGXTCHRM2CHRM1
SCHEMBL15121492 0.75 TAAR1 (0.58) TAAR1CMA1TAS1R3TAS1R1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627648-A1 17aHYDROXYLASE/C17,20-LYASE INHIBITORS Novartis AG (CH) 2013-08-21 EP disclosed
WO-2012035078-A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS NOVARTIS AG (CH) 2012-03-22 WO disclosed